medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2015, Number S1

<< Back Next >>

Rev Mex Anest 2015; 38 (S1)

Pharmacological interactions of chemotherapy and anesthesia

Cuéllar-Garduño N

Language: Spanish
References: 21
Page: 159-162
PDF size: 159.26 Kb.


Text Extraction

No abstract.


REFERENCES

  1. www.who.int/

  2. Zaniboni A, Prabhu S, Audisio RA. Chemotherapy and anaesthetic drugs: too little is known. Lancet Oncol. 2005;6:176-181.

  3. Holmes S. Making sense of cancer chomotherapy. Nurs Times. 1996;92:42-43.

  4. Kiyomiya K, Matsuo S, Kurebe M. Differences in intracellular sites of action of Adriamycin in neoplastic and normal differentiated cells. Cancer Chemother Pharmacol. 2001;47:51-56.

  5. Flórez J, Armijo JA, Mediavilla A. Farmacología Humana. Cap. 61 y 62: Quimioterapia antineoplásica I y II. 4a. edición, Ed. Masson, 2004. pp. 1039-1078.

  6. Lefort AT. Perioperative management of the patient with cancer. Chest. 1999;115:165S-171S.

  7. Huettermann E, Junker T, Chatzinikolaou KP. The influence of anthracycline therapy on cardiac function Turing anesthesia. Anesth Analg. 2004;98:941-947.

  8. Huettemann E, Sakka SG. Anaesthesia and anti-cancer chemotherapeutic drugs. Curr Opin Anaesthesiol. 2005;18:307-314.

  9. Baumhakel M, Kasel D, Rao-Schymanski RA, et al. Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. Int J Clin Pharmacol Ther. 2001;39:517-528.

  10. Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol. 2004;5:489-496.

  11. Kvolik S, Glavas-Obrovac L, Sakic L, Margaretic D, Karner I. Anesthetic implications of anticancer chemotherapy. Eur J Anaesthesiol. 2003;20:859-871.

  12. Chlebowski RT, Block JB, Cundiff D, et al. Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line. Cancer Treat Rep. 1982;66:121-125.

  13. Kennedy KA, Hait WN, Lazo JS. Chemical modulation of bleomycin induced toxicity. Int J Radiat Oncol Biol Phys. 1986;12:1367-1370.

  14. Ermens AA, Schoester M, Spijkers LJ, et al. Toxicity of methotrexate in rats preexposed to nitrous oxide. Cancer Res. 1989;49:6337-6341.

  15. Rosenow S, Kooistra KL, Powis G, et al. Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane. Cancer Chemother Pharmacol. 1986;16:35-42.

  16. Rudnick S, Stevenson GW, Hall SC, et al. Halothane potentiates the anti- tumor activity of gamma-interferon and mimics calmodulin-blocking agents. Anesthesiology. 1991;74:115-119.

  17. Arian MR, Buggy DJ. Anaesthesia for cancer patients. Curr Opin Anaesthesiol. 2007;20:247-253.

  18. Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF, et al. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol. 2003;63:81-86.

  19. Walker IR, Zapf PW, Mackay IR. Cyclophosphamide, cholinesterase and anesthesia. Aust N Z J Med. 1972;2:247-251.

  20. Frenia ML, Long KS. Methotrezate and NSAID interactions. Ann Pharmacother. 1992;26:234-237.

  21. Gehdoo RP. Anticancer chemotherapy and it’s anaesthetic implications (Current Concepts). Indian J Anaesth. 2009;53:18-29.




2020     |     www.medigraphic.com